Pages that link to "Q42769359"

The following pages link to The importance of injecting vaccines into muscle. Different patients need different needle sizes (Q42769359):

Displaying 47 items.

• Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in women (Q23924129) (← links)
• Needle size for vaccination procedures in children and adolescents (Q24187107) (← links)
• Needle size for vaccination procedures in children and adolescents (Q24200692) (← links)
• Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus (Q28067143) (← links)
• Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum (Q30413366) (← links)
• Comparing Anti-hepatitis B Antibody Level in Iranian Obese or Overweight with Non-obese Cases (Q33566391) (← links)
• The safety and efficacy of the tetanus vaccine intramuscularly versus subcutaneously in anticoagulated patients: a randomized clinical trial (Q34151268) (← links)
• Influence of skin-to-muscle and muscle-to-bone thickness on depth of needle penetration in adults at the deltoid intramuscular injection site (Q34466920) (← links)
• Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial. (Q35039184) (← links)
• Immunization of patients with bleeding disorders (Q35544350) (← links)
• A systematic review to ascertain whether the standard needle is more effective than a longer or wider needle in reducing the incidence of local reaction in children receiving primary immunization (Q35696670) (← links)
• Obesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected Persons (Q36241275) (← links)
• BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses (Q36763266) (← links)
• Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization (Q36882535) (← links)
• Intramuscular injections: a review of best practice for mental health nurses. (Q37153813) (← links)
• Vaccine injection technique and reactogenicity--evidence for practice (Q37274133) (← links)
• Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly. (Q37713779) (← links)
• Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination (Q37904205) (← links)
• Rehmannia glutinosa polysaccharide induces toll-like receptor 4 dependent spleen dendritic cell maturation and anti-cancer immunity. (Q38622791) (← links)
• Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines? (Q38886698) (← links)
• Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K. (Q40744512) (← links)
• Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface (Q40817517) (← links)
• Importance of injecting vaccines into muscle. Parenteral vaccines must be given subcutaneously in patients with congenital bleeding disorders (Q41771800) (← links)
• Subcutaneous diphtheria and tetanus vaccines in children with haemophilia: A pilot study and review of the literature. (Q45870495) (← links)
• The introduction of the human papillomavirus vaccine - key issues (Q46095479) (← links)
• Boosting with recombinant MVA expressing M. tuberculosis α-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs (Q47155139) (← links)
• Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system (Q50859911) (← links)
• Patient satisfaction with an injection device for multiple sclerosis treatment (Q51280950) (← links)
• Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults (Q51752825) (← links)
• Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity. (Q52887008) (← links)
• Risk of bursitis and other injuries and dysfunctions of the shoulder following vaccinations. (Q54360478) (← links)
• Vaccination against canine parvoviral enteritis in healthy dogs. (Q54703466) (← links)
• Needle size for vaccination procedures in children and adolescents (Q57688932) (← links)
• Epinephrine: The Drug of Choice for Anaphylaxis--A Statement of the World Allergy Organization (Q59218206) (← links)
• Knowledge and Perceptions of Adverse Events Following Immunization among Healthcare Professionals in Africa: A Case Study from Ghana (Q64118850) (← links)
• Getting it in the right spot: Shoulder injury related to vaccine administration (SIRVA) and other injection site events (Q64323999) (← links)
• [Vaccination: information, precautions and technique] (Q74179004) (← links)
• Influenza vaccine failure: failure to protect or failure to understand? (Q89041842) (← links)
• Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge (Q89836502) (← links)
• A narrative review of the success of intramuscular gluteal injections and its impact in psychiatry (Q90468190) (← links)
• Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010-2017 (Q91556278) (← links)
• Septic Shoulder Joint After Pneumococcal Vaccination Requiring Surgical Debridement (Q91787374) (← links)
• Injectable Biodegradable Chitosan-Alginate 3D Porous Gel Scaffold for mRNA Vaccine Delivery (Q93170301) (← links)
• Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Alum Induces Protective Immunity and Reduces Immune Enhancement (Q95627691) (← links)
• Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project (Q95728190) (← links)
• BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis (Q99726605) (← links)
• Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement (Q100514972) (← links)